Your browser doesn't support javascript.
loading
Anatomic position determines oncogenic specificity in melanoma.
Weiss, Joshua M; Hunter, Miranda V; Cruz, Nelly M; Baggiolini, Arianna; Tagore, Mohita; Ma, Yilun; Misale, Sandra; Marasco, Michelangelo; Simon-Vermot, Theresa; Campbell, Nathaniel R; Newell, Felicity; Wilmott, James S; Johansson, Peter A; Thompson, John F; Long, Georgina V; Pearson, John V; Mann, Graham J; Scolyer, Richard A; Waddell, Nicola; Montal, Emily D; Huang, Ting-Hsiang; Jonsson, Philip; Donoghue, Mark T A; Harris, Christopher C; Taylor, Barry S; Xu, Tianhao; Chaligné, Ronan; Shliaha, Pavel V; Hendrickson, Ronald; Jungbluth, Achim A; Lezcano, Cecilia; Koche, Richard; Studer, Lorenz; Ariyan, Charlotte E; Solit, David B; Wolchok, Jedd D; Merghoub, Taha; Rosen, Neal; Hayward, Nicholas K; White, Richard M.
Affiliation
  • Weiss JM; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
  • Hunter MV; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cruz NM; Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Baggiolini A; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tagore M; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ma Y; Developmental Biology, The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Misale S; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Marasco M; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
  • Simon-Vermot T; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Campbell NR; Cell and Developmental Biology Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Newell F; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wilmott JS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Johansson PA; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Thompson JF; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA.
  • Long GV; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Pearson JV; Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mann GJ; Physiology, Biophysics & Systems Biology Graduate Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
  • Scolyer RA; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Waddell N; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Montal ED; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Huang TH; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Jonsson P; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Donoghue MTA; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Harris CC; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Taylor BS; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Xu T; Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Chaligné R; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Shliaha PV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Hendrickson R; John Curtin School of Medical Research, Australian National University, Acton, Australian Capital Territory, Australia.
  • Jungbluth AA; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales, Australia.
  • Lezcano C; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Koche R; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Studer L; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Ariyan CE; New South Wales Health Pathology, Sydney, New South Wales, Australia.
  • Solit DB; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Wolchok JD; School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
  • Merghoub T; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rosen N; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hayward NK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • White RM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature ; 604(7905): 354-361, 2022 04.
Article in En | MEDLINE | ID: mdl-35355015
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2022 Type: Article Affiliation country: United States